Circulating tumor DNA dynamic variation predicts sotorasib efficacy in KRASp.G12C-mutated advanced non-small cell lung cancer. Passiglia F, Pepe F, Russo G, Garbo E, et al. Cancer 2025;131:e35917.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Passiglia F, Pepe F, Russo G, Garbo E, et al. Circulating tumor DNA dynamic variation predicts sotorasib efficacy in KRASp.G12C-mutated advanced non-small cell lung cancer. Cancer 2025;131:e35917.
PMID: 40445863